Sonoma pharmaceuticals and microsafe group announce new epa claims and green seal certification for nanocyn(r) hospital-grade disinfectant

Boulder, co / accesswire / march 2, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology-based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the microsafe group dmcc, are excited to announce that nanocyn® hospital-grade disinfectant has received additional claims from the u.s. environmental protection agency (epa) for effective use against methicillin resistant staphylococcus aureus (mrsa), salmonella, norovirus, poliovirus, and as a fungicide. moreover, nanocyn® has also received the esteemed green seal® certification after surpassing a series of rigrous standards that measure environmental health, sustainability and product performance.
SNOA Ratings Summary
SNOA Quant Ranking